Albites-Sanabria, Jose
Palumbo, Pierpaolo
Bandinelli, Stefania
D’Ascanio, Ilaria
Mellone, Sabato
Paraschiv-Ionescu, Anisoara
Küderle, Arne
Cereatti, Andrea
Del Din, Silvia
Kluge, Felix
Gazit, Eran
Jansen, Carl-Philipp
Delgado-Ortiz, Laura
Garcia-Aymerich, Judith
Rochester, Lynn
Klenk, Jochen
Ferrucci, Luigi
Becker, Clemens
Chiari, Lorenzo
Palmerini, Luca
Funding for this research was provided by:
Seventh Framework Programme (288940)
Horizon 2020 (820820, 820820, 820820, 820820, 820820, 820820, 820820, 820820, 820820, 820820, 820820, 820820, 820820, 820820, 820820, 820820)
Article History
Received: 24 March 2025
Accepted: 6 June 2025
First Online: 5 July 2025
Competing interests
: S.M., L.P. and L.C. are co-founders and own shares of mHealth Technologies. S.D.D. reports consultancy activity with Hoffmann-La Roche Ltd. outside of this study. The remaining authors declare no competing interests.